Cite
HARVARD Citation
Takeda, Y. et al. (2022). The efficacy profiles of concurrent chemoradiotherapy with intensity-modulated radiotherapy followed by durvalumab in patients with unresectable stage III non–small cell lung cancer: A multicenter retrospective cohort study. Clinical and translational radiation oncology. pp. 57-63. [Online].